| Elizabeth Ann Ignacio, MD | |
|
71 Kamaiki Cir, Kahului, HI 96732-3153 | |
| (808) 250-7058 | |
| Not Available |
| Full Name | Elizabeth Ann Ignacio |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 28 Years |
| Location | 71 Kamaiki Cir, Kahului, Hawaii |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720159593 | NPI | - | NPPES |
| 034279500 | Medicaid | DC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 15771 (Hawaii) | Secondary |
| 2085R0204X | Radiology - Vascular & Interventional Radiology | MD 32700 (District Of Columbia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maui Memorial Medical Center | Wailuku, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Renaissance Imaging Medical Associates Inc | 7315841756 | 132 |
News Archive
Researchers at Washington University School of Medicine in St. Louis have shown once again that "ready, fire, aim," nonsensical though it may sound, can be an essential approach to research.
Democrats are likely to again push to give billions in health coverage assistance to Ground Zero workers when they return from their recess, Roll Call reports. "A Democratic leadership aide said Tuesday that the bill likely would get the green light for floor action shortly after the House returns Sept. 14 in conjunction with events planned to commemorate the ninth anniversary of the Sept. 11 terrorist attacks."
In September 2018, the National Institute of Allergy and Infectious Diseases, part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the burden of tuberculosis.
A pill containing 3 anti-HIV drugs designed specifically for children has been given tentative approval by the United States Food and Drug Administration (FDA). Its use in Sub-Saharan Africa will benefit thousands of children living with HIV.
Midgut neuroendocrine tumors are a rare type of cancer that develops in the small intestine and colon. Roughly 12,000 people are diagnosed with this disease each year. In January, the United Stated Food and Drug Administration approved Lutathera, a first-of-its-kind peptide receptor radionuclide therapy.
› Verified 7 days ago
| Entity Name | Straub Clinic & Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457306508 PECOS PAC ID: 6305759754 Enrollment ID: O20031111000417 |
News Archive
Researchers at Washington University School of Medicine in St. Louis have shown once again that "ready, fire, aim," nonsensical though it may sound, can be an essential approach to research.
Democrats are likely to again push to give billions in health coverage assistance to Ground Zero workers when they return from their recess, Roll Call reports. "A Democratic leadership aide said Tuesday that the bill likely would get the green light for floor action shortly after the House returns Sept. 14 in conjunction with events planned to commemorate the ninth anniversary of the Sept. 11 terrorist attacks."
In September 2018, the National Institute of Allergy and Infectious Diseases, part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the burden of tuberculosis.
A pill containing 3 anti-HIV drugs designed specifically for children has been given tentative approval by the United States Food and Drug Administration (FDA). Its use in Sub-Saharan Africa will benefit thousands of children living with HIV.
Midgut neuroendocrine tumors are a rare type of cancer that develops in the small intestine and colon. Roughly 12,000 people are diagnosed with this disease each year. In January, the United Stated Food and Drug Administration approved Lutathera, a first-of-its-kind peptide receptor radionuclide therapy.
› Verified 7 days ago
| Entity Name | Hilo Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962584060 PECOS PAC ID: 1254422900 Enrollment ID: O20070809000268 |
News Archive
Researchers at Washington University School of Medicine in St. Louis have shown once again that "ready, fire, aim," nonsensical though it may sound, can be an essential approach to research.
Democrats are likely to again push to give billions in health coverage assistance to Ground Zero workers when they return from their recess, Roll Call reports. "A Democratic leadership aide said Tuesday that the bill likely would get the green light for floor action shortly after the House returns Sept. 14 in conjunction with events planned to commemorate the ninth anniversary of the Sept. 11 terrorist attacks."
In September 2018, the National Institute of Allergy and Infectious Diseases, part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the burden of tuberculosis.
A pill containing 3 anti-HIV drugs designed specifically for children has been given tentative approval by the United States Food and Drug Administration (FDA). Its use in Sub-Saharan Africa will benefit thousands of children living with HIV.
Midgut neuroendocrine tumors are a rare type of cancer that develops in the small intestine and colon. Roughly 12,000 people are diagnosed with this disease each year. In January, the United Stated Food and Drug Administration approved Lutathera, a first-of-its-kind peptide receptor radionuclide therapy.
› Verified 7 days ago
| Entity Name | Renaissance Imaging Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487608931 PECOS PAC ID: 7315841756 Enrollment ID: O20171213001814 |
News Archive
Researchers at Washington University School of Medicine in St. Louis have shown once again that "ready, fire, aim," nonsensical though it may sound, can be an essential approach to research.
Democrats are likely to again push to give billions in health coverage assistance to Ground Zero workers when they return from their recess, Roll Call reports. "A Democratic leadership aide said Tuesday that the bill likely would get the green light for floor action shortly after the House returns Sept. 14 in conjunction with events planned to commemorate the ninth anniversary of the Sept. 11 terrorist attacks."
In September 2018, the National Institute of Allergy and Infectious Diseases, part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the burden of tuberculosis.
A pill containing 3 anti-HIV drugs designed specifically for children has been given tentative approval by the United States Food and Drug Administration (FDA). Its use in Sub-Saharan Africa will benefit thousands of children living with HIV.
Midgut neuroendocrine tumors are a rare type of cancer that develops in the small intestine and colon. Roughly 12,000 people are diagnosed with this disease each year. In January, the United Stated Food and Drug Administration approved Lutathera, a first-of-its-kind peptide receptor radionuclide therapy.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Ann Ignacio, MD 71 Kamaiki Cir, Kahului, HI 96732-3153 Ph: (808) 250-7058 | Elizabeth Ann Ignacio, MD 71 Kamaiki Cir, Kahului, HI 96732-3153 Ph: (808) 250-7058 |
News Archive
Researchers at Washington University School of Medicine in St. Louis have shown once again that "ready, fire, aim," nonsensical though it may sound, can be an essential approach to research.
Democrats are likely to again push to give billions in health coverage assistance to Ground Zero workers when they return from their recess, Roll Call reports. "A Democratic leadership aide said Tuesday that the bill likely would get the green light for floor action shortly after the House returns Sept. 14 in conjunction with events planned to commemorate the ninth anniversary of the Sept. 11 terrorist attacks."
In September 2018, the National Institute of Allergy and Infectious Diseases, part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the burden of tuberculosis.
A pill containing 3 anti-HIV drugs designed specifically for children has been given tentative approval by the United States Food and Drug Administration (FDA). Its use in Sub-Saharan Africa will benefit thousands of children living with HIV.
Midgut neuroendocrine tumors are a rare type of cancer that develops in the small intestine and colon. Roughly 12,000 people are diagnosed with this disease each year. In January, the United Stated Food and Drug Administration approved Lutathera, a first-of-its-kind peptide receptor radionuclide therapy.
› Verified 7 days ago
Dr. Scott R. Boren, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 140 Hoohana St Ste 209, Kahului, HI 96732 Phone: 808-243-6000 | |
Dr. Ronald M Boyd, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 53 S Puunene Ave Ste 115, Kahului, HI 96732 Phone: 808-877-6402 Fax: 808-871-5587 | |
Dr. David Joseph Heeney, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 53 S Puunene Ave Ste 115, Kahului, HI 96732 Phone: 808-877-6402 Fax: 808-871-5587 | |
Dr. David P. Dalzell, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2 Kiekiena Pl, Kahului, HI 96732 Phone: 888-318-8900 Fax: 408-370-9131 |